Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hrishikesh Samant

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 2, 2022
Clinical Presentation of Hepatocellular Carcinoma in African Americans vs. Caucasians: A Retrospective AnalysisHrishikesh Samant, Kapil Kohli, Krunal Patel, et al.
Clinical Transplantation|May 16, 2017
Kidney outcomes in patients with liver cirrhosis and chronic kidney disease receiving an orthotopic liver transplant aloneNeeraj Singh, Shahab Ahmadzadeh, Hosein Shokouh-Amiri, et al.
Journal of Gastrointestinal Oncology|March 14, 2024
Regorafenib combined with a PD-1 inhibitor in the second-line setting for unresectable hepatocellular carcinoma in real-world practiceHuaqiang Bi, Jun Pei, Kuansheng Ma, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 9, 2024
Association of statins with nonalcoholic fatty liver disease in patients with diabetesRaj Shah, Alexander Kong, Silvio De Melo, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 2, 2022
Risk Stratification in Post-ERCP Pancreatitis: How Do Procedures, Patient Characteristics and Clinical Indicators Influence Outcomes?Kapil Kohli, Hrishikesh Samant, Kashif Khan, et al.
Bioengineering (Basel, Switzerland)|February 13, 2019
3D Printing for Bio-Synthetic Biliary StentsChristen J Boyer, Moheb Boktor, Hrishikesh Samant, et al.
BMC Cancer|October 20, 2023
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysisHuilin Xu, Dedong Cao, Dingjie Zhou, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 19, 2022
SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver diseaseOscar Gomez-Torres, Shripa Amatya, Lilly Kamberov, et al.
International Journal of Biological Sciences|March 16, 2023
N<sup>6</sup>-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone MetastasisHao Zheng, Zhang-Jun Cheng, Bo Liang, et al.
Journal of Hepatology|May 8, 2026
A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular CarcinomaDavid J Taggart, Shivani Mahajan, Maxime A Gallant, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 2, 2022
Clinical Presentation of Hepatocellular Carcinoma in African Americans vs. Caucasians: A Retrospective AnalysisHrishikesh Samant, Kapil Kohli, Krunal Patel, et al.
Clinical Transplantation|May 16, 2017
Kidney outcomes in patients with liver cirrhosis and chronic kidney disease receiving an orthotopic liver transplant aloneNeeraj Singh, Shahab Ahmadzadeh, Hosein Shokouh-Amiri, et al.
Journal of Gastrointestinal Oncology|March 14, 2024
Regorafenib combined with a PD-1 inhibitor in the second-line setting for unresectable hepatocellular carcinoma in real-world practiceHuaqiang Bi, Jun Pei, Kuansheng Ma, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 9, 2024
Association of statins with nonalcoholic fatty liver disease in patients with diabetesRaj Shah, Alexander Kong, Silvio De Melo, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 2, 2022
Risk Stratification in Post-ERCP Pancreatitis: How Do Procedures, Patient Characteristics and Clinical Indicators Influence Outcomes?Kapil Kohli, Hrishikesh Samant, Kashif Khan, et al.
Bioengineering (Basel, Switzerland)|February 13, 2019
3D Printing for Bio-Synthetic Biliary StentsChristen J Boyer, Moheb Boktor, Hrishikesh Samant, et al.
BMC Cancer|October 20, 2023
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysisHuilin Xu, Dedong Cao, Dingjie Zhou, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 19, 2022
SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver diseaseOscar Gomez-Torres, Shripa Amatya, Lilly Kamberov, et al.
International Journal of Biological Sciences|March 16, 2023
N<sup>6</sup>-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone MetastasisHao Zheng, Zhang-Jun Cheng, Bo Liang, et al.
Journal of Hepatology|May 8, 2026
A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular CarcinomaDavid J Taggart, Shivani Mahajan, Maxime A Gallant, et al.
Pageof 5